Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TF Fluarix versus Fluzone in young children
2015-001258-13Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fluarix and Fluzone Trivalent in influenza (3 arms), sponsored by GSK. Primary endpoint: Serum anti-HA antibody titer against each of the three vaccine strains.
02
Drugs
FluarixFluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-001258-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001258-13.